Celgene Corporation (CELG)

CELG (NASDAQ:Drugs)
$141.51
pos +0.00
+0.00%
Today's Range: 140.29 - 144.07 | CELG Avg Daily Volume: 3,914,100
Last Update: 04/17/14 - 3:59 PM EDT
Volume: 0
YTD Performance: -16.25%
Open: $0.00
Previous Close: $141.86
52 Week Range: $110.53 - $174.66
Oustanding Shares: 406,020,079
Market Cap: 57,455,901,379
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 19 21 22 20
Moderate Buy 2 2 2 2
Hold 3 3 3 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.31 1.30 1.25
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 45.61
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
45.61 42.00 29.08
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-15.28% 16.62% 148.35%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.90 0.79 0.21
Net Income -0.40 0.65 0.18
EPS 2.00 0.84 0.22
Earnings for CELG:
EBITDA 2.35B
Revenue 6.49B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $1.43 $1.53 $6.34 $8.75
Number of Analysts 5 5 5 4
High Estimate $1.50 $1.62 $6.57 $9.90
Low Estimate $1.35 $1.47 $6.22 $7.82
Prior Year $1.25 $1.40 $5.36 $6.34
Growth Rate (Year over Year) 14.08% 9.00% 18.21% 38.10%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Apr 17, 2014 | 7:14 PM EDT

Maybe we can get some perspective about stocks that were loved.

By

Jim Cramer

 | Apr 17, 2014 | 1:12 PM EDT

Some unexpected stocks and sectors have climbed the market's wall of worry.

By

Jim Cramer

 | Apr 16, 2014 | 11:45 AM EDT

Algos think faster and react faster than humans can.

By

Jim Cramer

 | Apr 14, 2014 | 6:46 PM EDT

The voracious selling seems to have run its course.

By

Robert Lang

 | Apr 14, 2014 | 9:45 AM EDT

It's not just for the day off.

By

Bob Byrne

 | Apr 10, 2014 | 7:30 AM EDT

SPY and DIA are in balance and should be faded near their edges.

By

Jill Malandrino

 | Apr 9, 2014 | 1:35 PM EDT

Stephanie Link and Jill Malandrino review sector rotation and why stocks like Verizon, IBM, Celgene and Facebook are attractive relative to the areas seeing inflows.

By

Jim Cramer

 | Apr 7, 2014 | 5:49 PM EDT

Stocks get hammered again, but Facebook and Celgene hang tough.

By

Jim Cramer

 | Apr 1, 2014 | 3:08 PM EDT

TheStreet's Jim Cramer says investors need to see money come back to high-growth names, which have seen a shrinking price-to-earnings multiple.

By

Jim Cramer

 | Apr 1, 2014 | 2:13 PM EDT

Money managers need to be fashionable, and your advantage is that you don't.

The new Fed Chief said this at a recent meeting of the Economic Club of NY ... "We have in...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.